Sites not expected to fade away even as DCTs continue to grow past COVID-19.
Arnab Roy
Advertisement
Arnab Roy is a leader in ZS’s R&D excellence practice area and leads the development and global commercialization of ZS's DCT strategy and analytics solutions.
Articles by Arnab Roy
Identifying and providing clarity on the GCP quality and risk concerns associated with DCT modalities.
Assessing the opportunities, considerations and implications of decentralized trials—and why they’re here to stay
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
How AI Is Changing Endpoint Selection Before a Trial Even Starts
2
The Design Flaws Trial Simulations Surface That Traditional Planning Misses
3
Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It
4
ACT Brief: AI Expands Endpoint Options, CRO Oversight Documentation, and Kidney Cancer Approval
5